Cargando…

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine

The currently available antiviral treatments (Peg-Interferon-α and Nucleos(t)ide Analogues, NA) for chronic hepatitis B (CHB) achieve a functional cure (serum HBsAg and HDV-DNA clearance) of HBV infection in a limited number of patients. Nevertheless, the continuous pharmacological suppression of vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colombatto, Piero, Coco, Barbara, Bonino, Ferruccio, Brunetto, Maurizia R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027850/ https://www.ncbi.nlm.nih.gov/pubmed/35458431 http://dx.doi.org/10.3390/v14040701

Ejemplares similares

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
por: Bonino, Ferruccio, et al.
Publicado: (2022)

A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection
por: Brunetto, Maurizia Rossana, et al.
Publicado: (2014)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
por: Cavallone, Daniela, et al.
Publicado: (2023)

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease
por: Yuan, Quan, et al.
Publicado: (2015)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022)

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib
por: Colombatto, Piero, et al.
Publicado: (2021)

Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs
por: Novellino, Luisa, et al.
Publicado: (2012)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
por: De Rosa, Laura, et al.
Publicado: (2022)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
por: Marcellin, Patrick, et al.
Publicado: (2012)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent – A Critical Reasoning
por: Consolini, Rita, et al.
Publicado: (2022)

Thermal Care of Functional Dyspepsia Based on Bicarbonate-Sulphate-Calcium Water: A Sequential Clinical Trial
por: Rocca, Giuseppe, et al.
Publicado: (2007)

T cell receptor-therapy in HBV-related hepatocellularcarcinoma
por: Bertoletti, Antonio, et al.
Publicado: (2015)

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
por: Crotta, Stefania, et al.
Publicado: (2002)

Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral (18)FDG in Mice
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Maternal High-Fat Feeding Affects the Liver and Thymus Metabolic Axis in the Offspring and Some Effects Are Attenuated by Maternal Diet Normalization in a Minipig Model
por: La Rosa, Federica, et al.
Publicado: (2021)

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B
por: Lampertico, Pietro, et al.
Publicado: (2018)

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial
por: Colombatto, P, et al.
Publicado: (2014)

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
por: Mancini, Marcello, et al.
Publicado: (2018)

Personalized treatment of hepatitis B
por: Lok, Anna S.
Publicado: (2015)

Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet
por: Guzzardi, Maria Angela, et al.
Publicado: (2021)

Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
por: Stasi, Cristina, et al.
Publicado: (2018)

Toward personalized management of chronic hypertension in pregnancy
por: Magee, Laura A., et al.
Publicado: (2022)

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
por: Sonneveld, Milan J., et al.
Publicado: (2023)

Towards Personalized Medicine for Chronic Liver Disease
por: Gao, Jingwen, et al.
Publicado: (2023)

Towards personalized medicine in Ménière’s disease
por: Lopez-Escamez, Jose Antonio, et al.
Publicado: (2018)

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009)

Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010)

Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Chronic Hepatitis B Infection: New Approaches towards Cure
por: Ogunnaike, Mojisola, et al.
Publicado: (2023)

Prevention and Management of Chronic Hepatitis B
por: Bhat, Mamatha, et al.
Publicado: (2014)

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
por: Kim, Sun Woong, et al.
Publicado: (2022)

Unmet need in chronic hepatitis B management
por: Liang, Lilian Yan, et al.
Publicado: (2019)

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020)

Pharmacogenomics in osteoporosis: Steps toward personalized medicine
por: Greene, Robert, et al.
Publicado: (2009)

Towards Personalized Medicine in Psoriasis: Current Progress
por: Camela, Elisa, et al.
Publicado: (2022)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
por: Vachon, Alicia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4sdn5761mvipnu3n15ec6j85sm